Clinical implications of tumor heterogeneity.
Schilsky
R L
RL
Director, Joint Section of Hematology-Oncology, University of Chicago, Pritzker School of Medicine, IL.
D004351:Drug Resistance; D006801:Humans; D009369:Neoplasms / Q000235:genetics / Q000473:pathology* / Q000628:therapy; D010641:Phenotype